title: The prostaglandin E(2) system: a toolbox for skeletal repair?
authors.forename: Kolja
authors.initials: K
authors.lastname: Gelse
authors.forename: Christian
authors.initials: C
authors.lastname: Beyer
mesh_terms: D000818:Animals; D001847:Bone Diseases / Q000188:drug therapy / Q000503:physiopathology*; D055396:Bone Morphogenetic Protein 2 / Q000494:pharmacology / Q000627:therapeutic use; D015232:Dinoprostone / Q000502:physiology*; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D006706:Homeostasis / Q000187:drug effects / Q000502:physiology*; D036341:Intercellular Signaling Peptides and Proteins / Q000494:pharmacology / Q000627:therapeutic use; D051379:Mice; D000080385:Nanogels; D010012:Osteogenesis / Q000187:drug effects / Q000502:physiology*; D011092:Polyethylene Glycols / Q000494:pharmacology / Q000627:therapeutic use; D011094:Polyethyleneimine / Q000494:pharmacology / Q000627:therapeutic use; D058309:Receptors, Prostaglandin E, EP4 Subtype / Q000819:agonists
chemical_list: C525719:Bmp2 protein, mouse; D055396:Bone Morphogenetic Protein 2; D036341:Intercellular Signaling Peptides and Proteins; D000080385:Nanogels; D058309:Receptors, Prostaglandin E, EP4 Subtype; C413692:polyethylene glycol polyethyleneimine nanogel; D011092:Polyethylene Glycols; D011094:Polyethyleneimine; D015232:Dinoprostone